The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2025
Synopsis
Thyroid cancer is the most common endocrine tumor. Four targeted agents (vandetanib, cabozantinib, sorafenib, and lenvatinib) have attained regulatory approval for advanced thyroid cancer, and several other related agents are now commonly used off-label as first- and second-line treatments for selected patients.
The global Medicine for the Treatment of Advanced Thyroid Cancer market was valued at US$ 438 million in 2023 and is anticipated to reach US$ 666.6 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Medicine for the Treatment of Advanced Thyroid Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine for the Treatment of Advanced Thyroid Cancer.
Report Scope
The Medicine for the Treatment of Advanced Thyroid Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medicine for the Treatment of Advanced Thyroid Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicine for the Treatment of Advanced Thyroid Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
AstraZeneca
Sanofi
Exelixis Inc.
Ipsen Pharma
Eisai Inc
Segment by Type
Cabozantinib
Sorafenib
Vandetanib
Lenvatinib
Segment by Application
Combination therapy
Solo Medication
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicine for the Treatment of Advanced Thyroid Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicine for the Treatment of Advanced Thyroid Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Thyroid cancer is the most common endocrine tumor. Four targeted agents (vandetanib, cabozantinib, sorafenib, and lenvatinib) have attained regulatory approval for advanced thyroid cancer, and several other related agents are now commonly used off-label as first- and second-line treatments for selected patients.
The global Medicine for the Treatment of Advanced Thyroid Cancer market was valued at US$ 438 million in 2023 and is anticipated to reach US$ 666.6 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Medicine for the Treatment of Advanced Thyroid Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicine for the Treatment of Advanced Thyroid Cancer.
Report Scope
The Medicine for the Treatment of Advanced Thyroid Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medicine for the Treatment of Advanced Thyroid Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicine for the Treatment of Advanced Thyroid Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
AstraZeneca
Sanofi
Exelixis Inc.
Ipsen Pharma
Eisai Inc
Segment by Type
Cabozantinib
Sorafenib
Vandetanib
Lenvatinib
Segment by Application
Combination therapy
Solo Medication
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicine for the Treatment of Advanced Thyroid Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicine for the Treatment of Advanced Thyroid Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Medicine for the Treatment of Advanced Thyroid Cancer Market Overview
1.1 Product Overview and Scope of Medicine for the Treatment of Advanced Thyroid Cancer
1.2 Medicine for the Treatment of Advanced Thyroid Cancer Segment by Type
1.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2024-2030)
1.2.2 Cabozantinib
1.2.3 Sorafenib
1.2.4 Vandetanib
1.2.5 Lenvatinib
1.3 Medicine for the Treatment of Advanced Thyroid Cancer Segment by Application
1.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value by Application: (2024-2030)
1.3.2 Combination therapy
1.3.3 Solo Medication
1.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size Estimates and Forecasts
1.4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue 2019-2030
1.4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales 2019-2030
1.4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medicine for the Treatment of Advanced Thyroid Cancer Market Competition by Manufacturers
2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price by Manufacturers (2019-2024)
2.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
2.7 Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation and Trends
2.7.1 Medicine for the Treatment of Advanced Thyroid Cancer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players Market Share by Revenue
2.7.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medicine for the Treatment of Advanced Thyroid Cancer Retrospective Market Scenario by Region
3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2019-2030
3.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2019-2024
3.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2025-2030
3.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2019-2030
3.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2019-2024
3.3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2025-2030
3.4 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.4.1 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2030)
3.4.3 North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.5.1 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2030)
3.5.3 Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.6.1 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2030)
3.6.3 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.7.1 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2030)
3.7.3 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2019-2030)
4.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2019-2024)
4.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2025-2030)
4.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2019-2030)
4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2019-2030)
4.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2019-2024)
4.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2025-2030)
4.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2019-2030)
4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2019-2030)
5.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2019-2024)
5.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2025-2030)
5.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2019-2030)
5.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2019-2030)
5.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2019-2024)
5.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2025-2030)
5.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2019-2030)
5.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Exelixis Inc.
6.4.1 Exelixis Inc. Corporation Information
6.4.2 Exelixis Inc. Description and Business Overview
6.4.3 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.4.5 Exelixis Inc. Recent Developments/Updates
6.5 Ipsen Pharma
6.5.1 Ipsen Pharma Corporation Information
6.5.2 Ipsen Pharma Description and Business Overview
6.5.3 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.5.5 Ipsen Pharma Recent Developments/Updates
6.6 Eisai Inc
6.6.1 Eisai Inc Corporation Information
6.6.2 Eisai Inc Description and Business Overview
6.6.3 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.6.5 Eisai Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Chain Analysis
7.2 Medicine for the Treatment of Advanced Thyroid Cancer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicine for the Treatment of Advanced Thyroid Cancer Production Mode & Process
7.4 Medicine for the Treatment of Advanced Thyroid Cancer Sales and Marketing
7.4.1 Medicine for the Treatment of Advanced Thyroid Cancer Sales Channels
7.4.2 Medicine for the Treatment of Advanced Thyroid Cancer Distributors
7.5 Medicine for the Treatment of Advanced Thyroid Cancer Customers
8 Medicine for the Treatment of Advanced Thyroid Cancer Market Dynamics
8.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Trends
8.2 Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
8.3 Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
8.4 Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation by Manufacturers in 2023
Table 4. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Medicine for the Treatment of Advanced Thyroid Cancer, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
Table 12. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medicine for the Treatment of Advanced Thyroid Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for the Treatment of Advanced Thyroid Cancer as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2019-2024) & (K Units)
Table 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2019-2024)
Table 19. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2025-2030) & (K Units)
Table 20. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2025-2030)
Table 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2019-2024)
Table 23. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2025-2030)
Table 25. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2024) & (K Units)
Table 27. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2025-2030) & (K Units)
Table 28. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2024) & (K Units)
Table 32. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2025-2030) & (K Units)
Table 33. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2019-2024)
Table 51. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2025-2030)
Table 52. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2019-2024)
Table 53. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2025-2030)
Table 54. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2019-2024)
Table 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2025-2030)
Table 58. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2019-2024)
Table 59. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2025-2030)
Table 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2019-2024)
Table 61. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2025-2030)
Table 62. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2019-2024)
Table 63. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2025-2030)
Table 64. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2019-2024)
Table 67. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2025-2030)
Table 68. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2019-2024)
Table 69. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 74. Bayer Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Exelixis Inc. Corporation Information
Table 86. Exelixis Inc. Description and Business Overview
Table 87. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 89. Exelixis Inc. Recent Developments/Updates
Table 90. Ipsen Pharma Corporation Information
Table 91. Ipsen Pharma Description and Business Overview
Table 92. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 94. Ipsen Pharma Recent Developments/Updates
Table 95. Eisai Inc Corporation Information
Table 96. Eisai Inc Description and Business Overview
Table 97. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product
Table 99. Eisai Inc Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Medicine for the Treatment of Advanced Thyroid Cancer Distributors List
Table 103. Medicine for the Treatment of Advanced Thyroid Cancer Customers List
Table 104. Medicine for the Treatment of Advanced Thyroid Cancer Market Trends
Table 105. Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
Table 106. Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
Table 107. Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medicine for the Treatment of Advanced Thyroid Cancer
Figure 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Type in 2023 & 2030
Figure 4. Cabozantinib Product Picture
Figure 5. Sorafenib Product Picture
Figure 6. Vandetanib Product Picture
Figure 7. Lenvatinib Product Picture
Figure 8. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Application in 2023 & 2030
Figure 10. Combination therapy
Figure 11. Solo Medication
Figure 12. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size (2019-2030) & (US$ Million)
Figure 14. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (2019-2030) & (K Units)
Figure 15. Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) & (2019-2030)
Figure 16. Medicine for the Treatment of Advanced Thyroid Cancer Report Years Considered
Figure 17. Medicine for the Treatment of Advanced Thyroid Cancer Sales Share by Manufacturers in 2023
Figure 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players: Market Share by Revenue in 2023
Figure 20. Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2019-2030)
Figure 23. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2019-2030)
Figure 27. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2019-2030)
Figure 28. Germany Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2019-2030)
Figure 35. China Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2019-2030)
Figure 46. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2019-2030)
Figure 56. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2019-2030)
Figure 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2019-2030)
Figure 59. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2019-2030)
Figure 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2019-2030)
Figure 61. Medicine for the Treatment of Advanced Thyroid Cancer Value Chain
Figure 62. Medicine for the Treatment of Advanced Thyroid Cancer Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
